Multiple sclerosis: lessons from molecular neuropathology
about
Nonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis.Progressive multiple sclerosis: from pathogenic mechanisms to treatment.Primary Progressive Multiple Sclerosis: Putting Together the PuzzleEffects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.HLA-DRB1*15 influences the development of brain tissue damage in early PPMSResponse to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.Quantitative evaluation of cerebral white matter in patients with multiple sclerosis using multicomponent T2 mapping.The immunogenetics of multiple sclerosis: A comprehensive review.Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot studyOxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.A basic overview of multiple sclerosis immunopathology.Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation.Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies.Neuroprotection by Cocktails of Dietary Antioxidants under Conditions of Nerve Growth Factor DeprivationPeriventricular lesions correlate with cortical thinning in multiple sclerosis.Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis.The disruption of mitochondrial axonal transport is an early event in neuroinflammation.Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: Proof of concept in multiple sclerosis.Targets of therapy in progressive MS.The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies.Heterogeneity of Cortical Lesion Susceptibility Mapping in Multiple Sclerosis.Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model.GABA: a new imaging biomarker of neurodegeneration in multiple sclerosis?Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice.Untangling the R2* contrast in multiple sclerosis: A combined MRI-histology study at 7.0 Tesla.The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases
P2860
Q30871249-68091381-8A65-4986-A769-EB6E862A995AQ31139925-B633B8D4-595D-40EB-B795-2CDC0F93DA02Q33365606-21B84F70-9A72-4FAE-B5EF-9B07A38C4F69Q33934466-7587A3A8-A3AC-40CF-913F-B17591D4C575Q34468304-EBD7CC75-2A0F-4553-B2ED-770308DC4CDBQ34553785-53EFF665-320C-415A-B18D-279725CA5BC2Q35921568-EC878CF3-F92E-4323-B493-B564A7C5FE31Q35990016-F73BAEE5-C424-4742-B324-3523947491B9Q36394834-17CD8E9F-7E9F-4EE8-9D2D-645898885824Q37107063-8119D049-E2B8-4325-945A-89CF3BF51DE3Q37699846-75ABD9A1-E1CC-44B4-A403-891CDBDF69DEQ38569263-414B9C4D-7A34-423E-92B0-F6D10CEE2F55Q38587668-A6A2EF7D-DAC0-4342-A6A1-7E9C2CD15E15Q38809608-65E18186-57D6-4315-9E48-340A05C26186Q39069235-A5DFBB8B-E4B2-4101-902B-E46887298E29Q39091396-E4D8336F-77FE-41F8-8307-DDF734B656C9Q39188128-F77B6224-4AB0-4680-B887-4DF6BBC1D895Q40667021-4F80F3F8-6D68-4F9D-B0C2-F38E615B7BB6Q40825942-7D857ABD-CC90-4027-A830-42009618B191Q41139837-885D9286-CB61-48CE-9A24-7B1FEC16EFF5Q41966044-D6B9BD4F-CAB0-4039-8AD4-BF74842A4AFAQ42426175-926C238E-6589-4975-BC09-8316CC50E0DBQ47774503-A95E2F37-DE0D-44D8-A68C-D3FDF35F4572Q47870855-A982E123-C064-4616-B37C-D777551406CFQ48276487-3C505D84-8B5F-4695-99A4-6F35D86184EEQ48472483-E030D727-4306-43E4-A66E-4DAF610C6560Q52150610-08986C49-A66E-47B9-8DB6-17D92DE04076Q52338686-0151A9B0-86E9-4342-A64A-01994503D7F2Q55004364-E330B4EC-40E7-4B91-96AE-0D70F77BD29FQ58787876-94421F7A-2E57-4825-A28F-D30188ED206A
P2860
Multiple sclerosis: lessons from molecular neuropathology
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Multiple sclerosis: lessons from molecular neuropathology
@ast
Multiple sclerosis: lessons from molecular neuropathology
@en
Multiple sclerosis: lessons from molecular neuropathology
@nl
type
label
Multiple sclerosis: lessons from molecular neuropathology
@ast
Multiple sclerosis: lessons from molecular neuropathology
@en
Multiple sclerosis: lessons from molecular neuropathology
@nl
prefLabel
Multiple sclerosis: lessons from molecular neuropathology
@ast
Multiple sclerosis: lessons from molecular neuropathology
@en
Multiple sclerosis: lessons from molecular neuropathology
@nl
P1476
Multiple sclerosis: lessons from molecular neuropathology
@en
P2093
Hans Lassmann
P356
10.1016/J.EXPNEUROL.2013.12.003
P407
P478
P577
2013-12-14T00:00:00Z